HGH supplements for men are designed for bodybuilding and virility enhancing purposes that aid growth hormone production naturally. The method is not simple but it requires a lot of care and attention ...

ORLANDO, Florida — Two investigational long-acting growth-hormone (GH) replacement products hold potential for less frequent dosing and improved adherence among adult patients with proven ...

Sogroya is a long-acting form of somatropin. Somatropin is also called human growth hormone. Sogroya is made by attaching human growth hormone to a small protein that helps it stay in the body longer ...

The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...

> Genentech has introduced a new pre-filled, multi-dose injection device for the administration of Nutropin AQ, a recombinant growth hormone for patients with growth disorders. "NuSpin" is the first ...

March 5, 2010 — The US Food and Drug Administration (FDA) has approved a prefilled somatropin (rDNA origin) injection pen (Norditropin FlexPro, Novo Nordisk, Inc) for the treatment of growth hormone ...

New indications expand treatment options for appropriate children aged 2.5 years and older with Idiopathic Short Stature (ISS), born Small for Gestational Age (SGA), or Noonan Syndrome (NS) 1 Sogroya ...

It is now possible to study short-term growth by knemometry, a non-invasive technique measuring the exact distance between heel and knee in sitting children. During the measurement the lower leg ...

For the thousands of adults and children with growth hormone deficiencies, daily injections of replacement hormones are their best bet for preventing the cardiovascular, muscular and metabolic ...

A new study finds that human growth hormone (HGH) improves sprint capacity in healthy recreational athletes. This is the first trial to demonstrate that HGH improves athletic performance. A study ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya® (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...